Dutch Ophthalmic’s VisionBlue Detailing Will Cite Sterility Problems With Compounded Versions
This article was originally published in The Pink Sheet Daily
Executive Summary
Custom Rx Compounding Pharmacy issues a nationwide recall of all unexpired syringes of trypan blue 0.06% ophthalmic solution following two reports of vision loss.
You may also be interested in...
FDA Clears VisionBlue For Use In Ophthalmic Surgery
Dutch Ophthalmic’s VisionBlue is the first product approved for staining the anterior lens capsule during cataract surgery, FDA says. Safety and effectiveness of trypan blue ophthalmic solution were established in pediatric patients; no differences have been observed between elderly and younger patients.
Barr’s Expanded Thalidomide ANDA Could Increase Likelihood Of A Marketed Generic
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.
User Fee Deal For Ad Review Funds Stems From PhRMA DTC Principles
A draft agreement between industry and FDA that would assess user fees for "advisory review" of broadcast direct-to-consumer ads prior to initial public dissemination had its genesis in the Pharmaceutical Research & Manufacturers of America's DTC guiding principles